Lehigh Valley Business recently published an interview with HNL Genomic Scientist Dr. Geetika Trivedi, discussing the strides HNL is making into the field of genomics and how our local communities can benefit.
 
“HNL Lab Medicine knows the future of medicine is in diagnostics and is ramping up its use of genetic testing to help doctors find the right tools to treat patients quickly.
 
In addition to pathology tests, the company has moved into genomics to help the most severe cancer patients find the right "cocktail" to treat their specific needs and is testing COVID samples to see what variants are showing up in the area.
 
Geetika Trivedi, a clinical genomics scientist for HNL, said doctors have had access to genome testing, but in the past, had to send samples elsewhere to get results.
 
Now, they can send them to HNL, shortening the time it takes to determine the right course of treatment, which she said can save up to a week.”
 
Time is an incredibly important factor in medical treatment for many cancer patients, and the continued advances in testing at HNL will further position our local community to receive results, diagnoses and treatments faster.
 
In addition to cancer-focused Genomic testing, reporter Cris Collingwood spoke to Dr. Trivedi about utilizing genomic sequencing to map and track COVID-19 variants and identify mutations that might signify a new variant is on the rise. This capability helps HNL keep an eye on what variants are most predominant in our patients, as well as informs our scientists about what mutations might mean for new variants of COVID-19.
 
To read the full article, please visit https://www.lvb.com/hnl-lab-medicine-expanding-diagnostic-capabilities/